A semi-automatic methodology for analysing distributed and private biobanks

Näytä kaikki kuvailutiedot



Pysyväisosoite

http://hdl.handle.net/10138/330716

Lähdeviite

Almeida , J R , Pratas , D & Oliveira , J L 2021 , ' A semi-automatic methodology for analysing distributed and private biobanks ' , Computers in Biology and Medicine , vol. 130 , 104180 . https://doi.org/10.1016/j.compbiomed.2020.104180

Julkaisun nimi: A semi-automatic methodology for analysing distributed and private biobanks
Tekijä: Almeida, Joao Rafael; Pratas, Diogo; Oliveira, Jose Luis
Tekijän organisaatio: Department of Virology
University of Helsinki
Päiväys: 2021-03
Kieli: eng
Sivumäärä: 8
Kuuluu julkaisusarjaan: Computers in Biology and Medicine
ISSN: 0010-4825
DOI-tunniste: https://doi.org/10.1016/j.compbiomed.2020.104180
URI: http://hdl.handle.net/10138/330716
Tiivistelmä: Privacy issues limit the analysis and cross-exploration of most distributed and private biobanks, often raised by the multiple dimensionality and sensitivity of the data associated with access restrictions and policies. These characteristics prevent collaboration between entities, constituting a barrier to emergent personalized and public health challenges, namely the discovery of new druggable targets, identification of disease-causing genetic variants, or the study of rare diseases. In this paper, we propose a semi-automatic methodology for the analysis of distributed and private biobanks. The strategies involved in the proposed methodology efficiently enable the creation and execution of unified genomic studies using distributed repositories, without compromising the information present in the datasets. We apply the methodology to a case study in the current Covid-19, ensuring the combination of the diagnostics from multiple entities while maintaining privacy through a completely identical procedure. Moreover, we show that the methodology follows a simple, intuitive, and practical scheme.
Avainsanat: Genomics studies
Distributed biobanks
Genomics cross-exploration
Coronavirus 2
SARS-CoV-2
Secondary use
3111 Biomedicine
Vertaisarvioitu: Kyllä
Tekijänoikeustiedot: cc_by_nc_nd
Pääsyrajoitteet: openAccess
Rinnakkaistallennettu versio: publishedVersion


Tiedostot

Latausmäärä yhteensä: Ladataan...

Tiedosto(t) Koko Formaatti Näytä
1_s2.0_S0010482520305114_main.pdf 1.823MB PDF Avaa tiedosto

Viite kuuluu kokoelmiin:

Näytä kaikki kuvailutiedot